Drug intelligence / Profile preview

11C-PBR28 + 18F-Florbetaben

Development stage
Unknown
Lead developer
Lantheus
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

This is a combination of two PET radiotracers used in neuroimaging research, particularly for Alzheimer's disease and related neurodegenerative disorders. **11C-PBR28** is a second-generation radioligand that binds to the translocator protein (TSPO), which is upregulated in activated microglia, serving as a marker of neuroinflammation. **18F-florbetaben** is a fluorine-18 labeled stilbene derivative that binds specifically to β-amyloid plaques in the brain, allowing visualization and quantification of amyloid pathology. The combination enables simultaneous or sequential assessment of both amyloid deposition and neuroinflammation within the same subjects using PET imaging. This dual-tracer approach provides complementary information about two key pathological processes in Alzheimer's disease: amyloid accumulation and microglial activation[2][5][9].

Brand names
Neuraceq (for florbetaben F18)
Other names
[11C]PBR28[18F]florbetabenflorbetaben F18
02

Targets

TSPO (Translocator Protein (18 kDa))

Beyond the preview

Go deeper on 11C-PBR28 + 18F-Florbetaben.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 11C-PBR28 + 18F-Florbetaben.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call